Authored by Mayasari Lim, PhD, Jonathan Carson, PhD, and Jon A. Rowley, PhD, RoosterBio, Inc. Some research suggests that ARDS might be treatable with the secretome of MSCs. Scientists and ... More

By Jonathan Carson, PhD and Jon A. Rowley, PhD, with acknowledgement to scientists who sounded the alarm like Dr. Liz Specht and to all health workers on the front lines. ... More

Authored by Mayasari Lim | West Coast and APAC lead for RoosterBio   Amidst the scramble and panic-buying that some of us are experiencing, several treatments to combat this novel ... More

Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More

Originally Authored by Jon A. Rowley, PhD, Founder (February 15, 2014). Updated by Iain Farrance, PhD and Jon Carson, PhD  (February 5, 2020) What’s in a Name? MSC is the common ... More

Authored by Katrina Adlerz, Ph.D., Scientist, Analytics, Product & Process Development & Josephine Lembong, Ph.D., Scientist, Analytics, Product & Process Development The 2019 International Society for Cell and Gene Therapy (ISCT) ... More

Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More

Authored by Katrina Adlerz, Ph.D. Scientist, Analytical Development, RoosterBio Inc. RoosterBio attended the International Society for Cell Therapy annual meeting, held May 2-5, 2018 in Montreal, which brought together leaders ... More

  Fisher et al published the first attempt at engineering a full-scale adult human femur head from hMSCs.  This is the largest reported tissue to have been engineered and took ... More